Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention
FeelGood
1 other identifier
observational
125
0 countries
N/A
Brief Summary
Studies have shown that admission to hospital during a coronavirus epidemic is associated with increased levels of anxiety, depression and panic disorder. During the SARS-CoV-2 pandemic in North London the Royal Free Hospital admitted over 500 patients with Covid-19. As part of the standard of care, these patients are screened at 8 weeks post discharge for signs of anxiety and depression. The Feeling Good app is a NHS approved digital application which utilises applied relaxation, mindfulness based cognitive therapy and positive visualisation through audio tracks for the treatment of anxiety and depression. This is a naturalistic cohort study aimed to track the post illness psychological symptoms of those who have been admitted with Covid-19 to the Royal Free hospital up to 5-7 months after discharge. The study population is those who are exhibiting anxiety or depressive symptoms as measure by the PHQ-2 or TSQ questionnaires. All those with symptoms will be offered free access to a NHS approved app for anxiety and depression, and followed up for 3 months after recruitment to track changes to their symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2020
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2020
CompletedFirst Posted
Study publicly available on registry
June 29, 2020
CompletedStudy Start
First participant enrolled
August 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2021
CompletedAugust 28, 2020
August 1, 2020
2 months
June 11, 2020
August 26, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Anxiety as measured by generalised anxiety disorder score (GAD-7) scale
Generalised anxiety disorder score (GAD-7) scale. Score 0-21, with a higher score associated with greater anxiety symptoms. Scores of 5, 10, and 15 represent cut-points for mild, moderate, and severe anxiety, respectively. GAD-7 score at baseline will be controlled for.
Day 14
Secondary Outcomes (3)
Depression as measured by the patient health questionnaire 9 (PHQ-9)
14 days and week 12
Trauma as measured by Trauma screening questionnaire (TSQ)
12 weeks
Anxiety as measured by generalised anxiety disorder score (GAD-7) scale
Week 12
Other Outcomes (2)
Risk associated with distress
Baseline analysis
Qualitative analysis
Baseline
Study Arms (1)
Naturalistic cohort
Patients who were hospitalised between March and June from Covid19, who did not require treatment in intensive care, who at 8 weeks post discharge have symptoms of anxiety or depression. All patients are offered access to an audio based self help programme based on applied relaxation and mindfulness based cognitive therapy.
Interventions
Audio based tracks using Jacobson relaxation and mindfullness based cognitive therapy (MBCT) techniques including positive visualisation.
Eligibility Criteria
Patients who were hospitalised with Covid19 who have psychological symptoms 8 weeks after discharge. That is a \>=6 on TSQ or \>= 3 on PHQ9.
You may qualify if:
- Over the age of 18
- Treated for Covid-19 at the Royal Free Hospital
- Capacity to consent AND
- At screening had a PHQ-2 score \>=3 (positive) OR
- At screening had a TSQ score \>= 6 (positive)
You may not qualify if:
- A current inpatient
- Participant on alternative trial that excludes being in a secondary trial
- Patient currently using alternative MBCT app tool
- Patients under 18 years old
- Background of psychotic illness
- Patient declined
- Patient unable to consent
- Underlying cognitive impairment which may impede ability to comply with the intervention
- Severe hearing impairment
- Current delirium
- Was an in-patient in intensive care during hospital stay
- Unable to contact patient via telephone on 2 attempts Patient is not registered with a GP. Unable to understand English proficiently enough to engage with the audio tracks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Research and Development Manager
Sponsor GmbH
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2020
First Posted
June 29, 2020
Study Start
August 31, 2020
Primary Completion
October 31, 2020
Study Completion
January 31, 2021
Last Updated
August 28, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share